Literature DB >> 12012271

Morphological and enzymatic changes of the small intestine in an n0-STZ diabetes rat model.

M A Tormo1, I M Martínez, A Romero de Tejada, I Gil-Exojo, J E Campillo.   

Abstract

Summary. Many studies have shown that experimental type 1 diabetes causes morphological, functional, and metabolic alterations in the small intestine. The more frequent form of the disease, type 2 diabetes, however, has been less studied. Here the influence of diabetes on the functionality of the small intestine was studied in an experimental diabetes model, with a certain degree of residual insulin secretion, specifically in the n0-STZ model. - The diabetic rats in this model were found to have glycaemia levels higher than in the controls (8.82 +/- 0.27 and 6.18 +/- 0.18 mmol/L; p < 0.01), while their plasma insulin levels were lower than in the control rats (2.65 +/- 0.32 and 3.60 +/- 0.25 ng/ml; p < 0.05). Although there were no significant variations in body weight between the two groups, both the weight and the length of the intestine were significantly greater (p < 0.05) in the diabetic rats than in the controls. The sucrase and maltase activities were greater (p < 0.01) in the proximal intestine of the diabetic rats (94 +/- 8 and 234 +/- 12 mU/mg protein, respectively) than in the control rats (50 +/- 2 and 149 +/- 20 mU/mg protein, respectively). The 6-phosphofructo-1-kinase activity (mU/mg proteins) was less (p < 0.05) in the proximal and distal intestine of the diabetic rats (160 +/- 40 and 80 +/- 20, respectively) than in the controls (280 +/- 30 and 230 +/- 30, respectively). No significant differences were observed in the lactate dehydrogenase or active and total pyruvate dehydrogenase measured in the distal and proximal intestine of control and diabetic rats. In conclusion, our results show that experimental diabetes (n0-STZ model) similar to human type 2 diabetes produces certain morphological and enzymatic alterations which affect the digestion and absorption of carbohydrates and the intestinal metabolism of glucose. These alterations may contribute to producing the post-prandial hyperglycaemia which characterizes diabetes.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12012271     DOI: 10.1055/s-2002-29088

Source DB:  PubMed          Journal:  Exp Clin Endocrinol Diabetes        ISSN: 0947-7349            Impact factor:   2.949


  5 in total

1.  Berberine suppresses intestinal disaccharidases with beneficial metabolic effects in diabetic states, evidences from in vivo and in vitro study.

Authors:  Li Liu; Yun-Li Yu; Jian-Song Yang; Yang Li; Yao-Wu Liu; Yan Liang; Xiao-Dong Liu; Lin Xie; Guang-Ji Wang
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2010-03-13       Impact factor: 3.000

Review 2.  Upper gastrointestinal sensory-motor dysfunction in diabetes mellitus.

Authors:  Jingbo Zhao; Jens Brøndum Frøkjaer; Asbjørn Mohr Drewes; Niels Ejskjaer
Journal:  World J Gastroenterol       Date:  2006-05-14       Impact factor: 5.742

3.  Effects of dietary L-arginine supplementation on serum lipids and intestinal enzyme activities in diabetic rats.

Authors:  I Míguez; G Mariño; B Rodríguez; C Taboada
Journal:  J Physiol Biochem       Date:  2004-03       Impact factor: 4.158

4.  Effective Control of Postprandial Glucose Level through Inhibition of Intestinal Alpha Glucosidase by Cymbopogon martinii (Roxb.).

Authors:  Varsha Ghadyale; Shrihari Takalikar; Vivek Haldavnekar; Akalpita Arvindekar
Journal:  Evid Based Complement Alternat Med       Date:  2011-07-07       Impact factor: 2.629

Review 5.  Diabetes-induced mechanophysiological changes in the small intestine and colon.

Authors:  Mirabella Zhao; Donghua Liao; Jingbo Zhao
Journal:  World J Diabetes       Date:  2017-06-15
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.